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Recurrence of congenital diaphragmatic hernia (CDH) was retrospectively evaluated after 
correction with or without a patch in an institution where tension-free repair is advocated.  
Methods 
Demographics and outcomes of patients with a postero-lateral CDH repaired (2000-2016) were 
analysed (univariate tests and binary logistic regression adjusting for time since start of study, 
gender, defect side, liver herniation, patch, surgical approach, absence of postero-lateral rim 
and length of follow-up).  
Results 
Of 203 patients, 107 received a patch (P), and 96 were not patched (NP). Groups were not 
different for gestational age birthweight, gender, defect side and minimally-invasive approach 
rate. Preoperative ECMO incidence (P:29.9% vs. NP:2.1%, p<0.01), liver herniation (P:57.0% 
vs. NP:22.9%, p<0.01) and absence of a postero-lateral rim (P:61.7% vs. NP:8.3%, p<0.01) 
were higher in the P group. The mortality rate was 10.8% (P:15.0% vs. NP:6.2%, p=0.07). 
Recurrence was not different (P:9.3% vs. NP:4.2%, p=0.15). Multivariate analysis showed that 
recurrence was higher after thoracoscopy compared to open (OR=12.2 [2.2-68], p<0.01); 
neither the use of patch (OR=2.3, [0.5-10.4], p=0.28) nor any other factors were associated with 
recurrence. 
Conclusion 
In this single centre series where tension-free repair was advocated, patch repair of CDH was 
not associated with higher recurrence, though access route was. 
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1. Introduction 
Long-term outcomes of postero-lateral congenital diaphragmatic hernia (CDH) repair 
has improved constantly. While prenatal strategies aim to decrease pulmonary consequences of 
the defect [1], surgeons should have a particular interest in reducing the rate of post-operative 
recurrence leading to redo surgery.  
The recurrence of a CDH is either asymptomatic and diagnosed on a routine X-Ray or 
because of potentially life-threatening symptoms including respiratory distress, small bowel 
obstruction, and intestinal perforation. Several factors have been described in the literature to 
be associated with recurrence, including the nature of the defect [2,3] (large, right, absence of 
peripheral rim), associated conditions (severe pulmonary hypertension) and the surgical 
approach (use of patch, minimally-invasive approach). The CDH study group has therefore 
proposed a classification of the defect (from A: small to D: agenesia) that is correlated to the 
severity (associated anomalies, mortality) [4,5]. Historically, patch were typically placed if the 
defect was too large for a primary repair (even under tension). This strategy was supported by 
studies reporting higher rates of recurrence, bowel obstruction and long term skeletal deformity 
in patients with large defects [6,7]. On the other side, a tension-free repair, avoiding muscular 
injuries and subsequent weaknesses would represent an alternative in order to prevent 
recurrences but implies more frequently the use of a patch [8]. 
Minimally-invasive surgical repair is another debated issue. With the objective to 
decrease the hospital length of stay, the rate of intra-abdominal complications, i.e., adhesions 
and subsequently small bowel obstruction events, this alternative access was described two 
decades ago. The thoracoscopy provide a manageable working space which can be maintained 
at a low pressure once the viscera are reduced in the abdomen as opposed to the laparoscopy. 
However, some studies reported a higher risk of recurrence with this approach which could 
represent a step back compared to open abdominal repair [9,10].  
 
 Thus, this study aims to evaluate a single institution experience where a tension-free 
repair has been advocated for more than 17 years comparing the outcomes of patients in whom 
CDH was repaired with or without a patch. 
2. Method 
 
 After approval of the local audit department, we conducted a single centre retrospective 
study. All consecutive patients who underwent a surgical repair of a postero-lateral CDH in our 
department (tertiary centre) between January 2000 and December 2016 were included. The 
surgery was conducted by an experienced senior surgeon (a total of 9 surgeons over the period, 
no predisposition for the use of a patch). We did not include though patients who had a previous 
repair in other centres, patients who died before any surgical repair and patients presenting with 
an anterior diaphragmatic hernia (Morgagni-Larrey). The surgery was conducted after 
stabilization and performed either by ipsilateral transverse muscle cutting laparotomy, postero-
lateral cutting muscle thoracotomy, open laparoscopy (3 or 4 ports, 5 mm scope, 3 mm set of 
instruments) or open thoracoscopy (3 or 4 ports, 5 mm scope, 3 mm set of instruments). Once 
the viscera were reduced in the abdominal cavity, the defect was assessed and closed with 
interrupted non-absorbable stitches in a tension-free manner. A patch was used to avoid a repair 
under tension. In absence of a peripherical rim, pericostal stitches were performed. At the 
discretion of the surgeon in charge, the mesentery root was widened (± associated with 
appendectomy) in case of a malrotation potentially at risk of volvulus. The perioperative 
medical management was conducted initially in neonatal/paediatric intensive care unit, then in 
a standard paediatric ward following good practices. 
Data were collected through the electronic record system and all operative notes were 
reviewed. Data collected, if applicable, regarded: date of birth, gestational age at birth, date of 
surgery, late presenter (after 30 days of life), gender, prenatal diagnosis, lung-to-head ratio, 
prenatal herniation of the liver and/or the stomach in the chest, pre-operative extra corporeal 
membrane oxygenation (ECMO), pre-operative pulmonary hypertension (need of specific 
therapies), Apgar score at 5 minutes, elective intubation at birth, genetic condition, congenital 
cardiac anomalies, operative technique (laparotomy, laparoscopy, thoracotomy, thoracoscopy), 
side and size of the defect, the use of a patch (size, material), the position of the liver during 
surgery, the absence of a postero-lateral rim, the need of stitches around ribs, the widening of 
the mesenteric root, appendectomy, additional surgeries during the follow-up, the occurrence 
of necrotizing enterocolitis, recurrence of CDH and the date of redo surgery, death and date of 
death, occurrence of small bowel obstruction during the follow-up, the date of the last clinic 
appointment. Missing data regarded only continuous data and are mentioned in legends.  
 Medical conditions and outcomes of patients repaired with or without patch were 
analysed first using univariate tests (Fisher exact test or parametric or non-parametric t-test as 
appropriate -normality assessed with the Shapiro-Wilk test-, Prism v7 software) followed by a 
binary logistic regression adjusting for time since start of study (date of operation), gender, side 
of defect, liver up, use of a patch, surgical approach, absence of a postero-lateral rim and length 
of follow-up using IBM SPSS v24 software. A p value lesser than 0.05 was considered to be 




Over this 17-year period, 203 patients underwent primary repair of a CDH at our 
institution (flow chart in figure 1), 107 with a patch (P), 96 without (NP). A delayed 
presentation was present in 28 (13.8%) patients, who were operated upon at a median age of 
196 [28-2166] days. There were 175 cases repaired neonatally, of whom 95 patients (46.8%) 
were diagnosed prenatally at a gestational age of 21 [16-39] weeks. These were overrepresented 
in the P-group than in the non-NP-patch group (66.3% vs 25.0% respectively, p<0.01). The 
defect was located on the left in 79.3% patients.  
At birth (table 1), patients from both groups were not different in terms of gestational 
age at birth, birthweight. Apgar score was higher in the NP group than in the P group (mean 
8.2 [2-10] vs 7.5 [2-10]; p=0.03). In case of prenatal diagnosis, an immediate intubation before 
5 min was performed in 48 (50.5%) patients. A genetic condition was found in 11 (5.4%) 
patients (Trisomy 21, 18 and 22q11 del), a congenital cardiac anomaly in 12 (5.9%).  Patients 
repaired with a patch had more frequently with a pre-operative suprasystemic pulmonary 
hypertension than non-patched patients (57.9% vs 21.8%, respectively, p<0.01) and had more 
frequently ECMO (29.9% vs 2.1%, respectively, p<0.01).  
The surgery (table 2) was conducted at a median age of 7 [0-2166] days, and at 6 [0-
374] days for patient with a neonatal presentation. From the operative notes, we retrospectively 
evaluated the size of the defect and defined it following the CDH group classification [11]. A 
defect type A was found in 63 patients, a B in 58, a C in 66 and a D in 16 cases (table 2). A 
diaphragmatic rim was more frequently absent in patients repaired with a patch than without 
61.7% vs 8.3%, respectively, p<0.01) as was the per-operative liver herniation in the thorax 
(57.0% vs 22.9%, respectively, p<0.01). The repair was performed via laparotomy in 155 
patients, thoracotomy in 1, laparoscopy in 12 (8 conversions) and thoracoscopy in 36 patients 
(10 conversions, 7 laparotomy and 3 thoracotomy). A patch of a median diameter of 5.31.7 
cm was used to close the defect in 107 patients (polyethylene terephthalate 54, fibrine 1, 
polytetrafluoroethylen 4, polyesther 22, polypropylen 14, unknown 10). The rate of patch use, 
represented in figure 2, increased over the years from 26% in 2000 to 80% in 2016 (p<0.01). 
Stitches were performed around the ribs in 88 (43.3%) cases, more often in P group than in NP 
group (62.6% vs 21.8%, respectively, p<0.01). In addition, the mesentery root was widened for 
30 patients, associated with an additional prophylactic appendectomy as a part of the Ladd’s 
procedure. 
During the post-operative period, 4 episodes of NEC were diagnosed (3 treated 
medically and 1 operated for small bowel perforation). A laparotomy was performed in 3 
patients for a pyloroplasty, for a duodenal perforation and for a duodenal obstruction.  
 Outcomes are represented in table 3. The follow-up period was comparable in both 
groups, as well as the recurrence rate (9.3% in the P versus 4.2% in the non-P, p=0.17). The 
delay for the diagnosis of recurrence seemed higher after patch repair (424 [64-2329]) than after 
primary repair (10 [24-174]) but was not statistically different (p=0.067). The incidence of 
recurrence by follow up period is illustrated in figure 2. A higher recurrence rate was seen 
between 2008 and 2012 in both groups. Among the 7 recurrences that occurred in non-
converted thoracoscopic repaired patients (n=26), 5 happened between 2007 and 2008 (13 
thoracoscopic repairs during this period). An episode of small bowel obstruction requiring a 
surgery was noticed in eight patients including three in the P group. Five patients required an 
additional fundoplication for severe gastro-oesophageal reflux and two patients had an 
additional Ladd’s procedure for malrotation. During the follow up period, the mortality rate 
was 10.8%, 15.0% after patch repair and 6.2% in the NP group (p=0.07). After patch repair, the 
majority (n=10/16, 62.5%) of infants died beyond 100 days of life as opposed to the patients 
deceased in the NP-group who (5/6) 83.3% died within the first month of life. 
Multivariate analysis using a binary logistic regression showed that recurrence was 
higher after thoracoscopic repair compared to open (OR 12.2 [2.2-68], p<0.01); neither the use 
of patch (OR 2.3, [0.5-10.4], p=0.28) nor any other factors were significant predictors of 
recurrence. Interestingly, we have observed this is possibly related to a learning curve with 
overall increase of recurrence free rate thoracoscopic repair for CDH repair with time (Figure 
4). 
 
We separately analysed outcomes of patients who had a prenatal assessment in our 
institution (n=52). Only one patient underwent a FETO procedure. The lung-to-head ratio 
(LHR) at presentation to the foetal medicine unit was measured at 1.3 [0.25-4.57] and the 
location of the liver and the stomach (chest or abdomen) was mentioned. The CDH Study Group 





 This study is, to our knowledge, the largest series of CDH repaired with a patch rate of 
over 50%. Over the past 15 years we have observed an increasing use of patches in patients 
with CDH. Because of the retrospective nature of the study, reasons could be different and 
maybe simply related to greater survival in high risk cases who require a patch. Reassuringly, 
the overall recurrence rate was low compared to previously reported data. Moreover, despite a 
large proportion of patients being repaired with a patch and a high incidence of factors 
reportedly associated with recurrence, in this group, i.e., use of ECMO before surgery, liver 
herniation and absence of rim [12], the recurrence rate was not statistically different.  
 
 In this study, the only factor associated with recurrence was the thoracoscopic approach. 
This result is consistent with previous meta-analyses [9,10] and this is possibly related to a 
learning curve. A thoracoscopic approach is still recommended in our institution for selected 
patients such as infants who are very stable or who present late. One of the factors that could 
explain the high recurrence rate could be the underestimation of the tension during the repair 
with the thoracoscopy, or to persist with the minimally invasive surgery when a patch is 
indicated that can be technically challenging and time consuming. In a previous study, however, 
the insertion of a patch during a thoracoscopic repair of CDH has been considered safe in terms 
of peri-operative morbidity, even if the duration of the procedure was longer [13]. Moreover, 
thoracoscopy is not contraindicated in newborn infants, as a relative hypercapnia can be 
tolerated without adverse effect, in particular in term of neurological development [14]. The 
majority of recurrences observed in this study happened at the beginning of our experience with 
thoracoscopy and the learning process may explain such a high recurrence rate. An algorithm 
has been published in order to help the decision for the thoracoscopic approach in stable patients 
[15] but further analyses should be done in order to assess the learning curve for safety of a 
thoracoscopic approach to repair a CDH, associated with the placement of a patch.  
 
 Another reason explaining the reluctance of certain surgeons to perform a thoracic 
approach is because it is almost impossible to assess hence treat small bowel malrotation. In 
our study, all patients operated on by an abdominal approach underwent an assessment for mid-
gut rotation. The mesentery was widened in 30 patients at the end of the procedure. This was 
not done in patients with a thoracoscopic repair but none of them presented with an acute 
volvulus during the follow-up period. The risk of volvulus was usually assessed by an upper 
gastro-intestinal tract contrast study and an additional Ladd’s procedure was performed if 
indicated. The operation was performed laparoscopically in most cases and results were 
reported in a recently published study[16]. 
  
 The risk of recurrence has been associated with the nature of defect and associated co-
morbidities. The CDH study group proposed a classification to highlight defect types and 
associated these with different outcomes [17]. The hypothesis was that larger defects would be 
correlated with more severe forms of lung hypoplasia. Patch repair has been highlighted to be 
potentially associated in higher recurrence rate [12]. In our series, where patch repair was 
widely represented, we did not observe a statistical difference in term of recurrence between P 
and NP patients. The majority of patches we used were made of polyester, but previous studies 
have shown that the results were similar whatever the material [18,19]. The tension-free 
approach which was also advocated in previous studies could be involved in those results. Some 
authors even recommend the use of a conic or dome shape patch allowing some sort of growth 
[8]. Interestingly, in our study, the recurrence occurred later in the group repaired in a patch 
than in the group repaired without patch and this could be the drawback of a synthetic patch 
that does not grow over the time. 
 
 We had 28 cases who presented late of whom only 6 were repaired with a patch. In 
keeping with previous studies, this subgroup of patients seems to have better outcomes than 
those presenting as neonates[20]. They may present less often with pulmonary hypoplasia 
and/or pulmonary hypertension and usually the defect is small and easy to close. None of these 
patients died in the follow-up and the recurrence rate was nil.  
 
The overall mortality in this study was 11%, 15% after patch repair versus 6% (p=0.07). 
This coincides with a higher severity at presentation in the patch group, given these patients 
were more likely on ECMO or presented with liver herniation or with an absent peripheral rim. 
Interestingly, in the patch repair group, most deaths occurred after 100 days of life, probably 
due to the consequences of the underlying lung disease whereas in the NP group most deaths 
occurred within the first 3 months of life.  
 
 One of the weakness of this study, due to its retrospective nature, is the absence of a 
picture of the defect and the conditions of repair. While the defect type was evocated, the size 
of the patch was often reported in the operative note. The absence of a rim was also consistently 
documented but its length was not. Finally, the tension applied to the repair was not assessed 
specifically and this could be a way to measure the risk of recurrence. Another weakness of this 
study is the absence of very long-term follow-up, i.e. after the end of growth, in order to 
evaluate the consequences of the patch use on the occurrence of chest deformities, scoliosis and 
pectus excavatum [21,22]. These issues might be solved in a long-term prospective cohort 
specifically designed to raise these concerns. Another lead would be provided by recent 
progress in tissue engineering that raised some interesting results in animal model of CDH [23]. 
This could provide a patch which can grow up with the patient and therefore bring the 
advantages of a lower rate of complication. 
 
In conclusion, in this single centre series, and with a liberal use of patched repairs, we 
observed a low recurrence rate, which was equal to that of unpatched repairs. Recurrence was 
higher in our early thoracoscopic experience. We suggest that use of a patch may represent a 
way to decrease the higher recurrence rate associated with this approach.  
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7. Figures and Tables  
 











Figure 1: selection of patients for the study 
  
265: All diagnosis of CDH 
251: Primary referral in our institution 
203: Patients with primary repair 
Dead before surgery (20) 
Surgery in other centre (14) 
Morgagni hernia (28) 






Figure 2: Incidence of patch use during the study period.  
The use of a patch to repair the defect is expressed as a percentage. A significant increase of 






















































































Figure 3: incidence of surgery performed without recurrence.  
The graph represents the percentage of procedures non-complicated by a recurrence. There was 
an increased recurrence rate between 2008 and 2012, concomitant with the beginning of the 































































































 Total (n=203) Patch (n=107)  No patch (n=96) p value 
Gestational age at birth 
(weeks), mean (range) 
38 [28-43] 38 [28-42] 38 [29-43] 0.24# 
Birth weight, mean (range) 3025 [905-6250] 2966 [905-4480] 3096 [1270-6250] 0.17# 
Males, n (%) 123 (60.6) 63 (58.9) 60 (62.5) 0.66† 
Prenatal diagnosis, n (%) 95 (46.8) 71 (66.3) 24 (25.0) <0.01† 
Neonatal diagnosis, n (%) 175 (86.2) 101 (94.4) 74 (77.1) <0.01† 
Preoperative ECMO, n (%) 34 (16.7) 32 (29.9) 2 (2.1) <0.01† 
Suprasystemic pulmonary 
hypertension, n (%) 
83 (40.9) 62 (57.9) 21 (21.8) <0.01† 
 
 
Table 1: initial clinical presentation 
#: two-sided Mann Whitney U-test for non-normal distribution. 
†: two-sided Fisher exact test 

















Left side, n (%) 161 (79.3) 80 (74.8) 81 (84.4) 0.12† 
Age at surgery (days), median 
(range) 
7 [0-2166] 10 [1-2166] 5 [0-1662] 0.013# 
For neonatal cases 6 [0-374] 8 [1-374] 3 [0-296] <0.001# 
Surgery before 30 days, n (%) 170 (83.7) 97 (90.7) 73 (76.1) 0.007† 


















Liver herniated, n (%) 83 (40.9) 61 (57.0) 22 (22.9) <0.001† 
Absence of rim, n (%) 74 (36.4) 66 (61.7) 8 (8.3) <0.001† 
Stitch around the ribs, n (%) 88 (43.3) 67 (62.6) 21 (21.8) <0.001† 
Type of defect 
A, n (%) 
B, n (%) 
C, n (%) 















Table 2: Operative findings in the two groups . 
#: two-sided Mann Whitney U-test for non-normal distribution. 
†: two-sided Fisher exact test 
‡: Chi-square test 
°: the last row was excluded for test applicability  
 
  








Recurrence, n (%) 14 (6.9) 10 (9.3) 4 (4.2) 0.17† 
Delay, median (range) 221 [10-2329] 424 [64-2329] 10 [24-174] 0.067# 
Mortality, n (%) 22 (10.8) 16 (15.0) 6 (6.2) 0.07† 
Before 30 days, n (%) 8 (36.4) 4 (25.0) 4 (66.6) 0.14† 
After 100 days, n (%) 11 (50.0) 10 (62.5) 1 (16.7) 0.15† 
Age of death, days median 
(range) 
108 [7-927] 148 [7-927] 25 [12-370] 0.17# 
Small bowel obstruction, n (%) 8 (3.9) 3 (2.8) 5 (5.2) 0.48† 
 
Table 3: Outcomes comparisons in the two groups.  
†: two-sided Fisher exact test 





  Total  Liver down Liver up 
Stomach down Stomach up Stomach down Stomach up 
n 52 8 (15.4) 28 (53.8) 5 (9.6) 10 (19.2) 
CDH Study 
Group score  
median, [range] 
2 [0-4] 1 [0-4] 1 [0-4] 2.5 [2-3] 2 [0-3] 
Defect 
A, n (%) 
B, n (%) 
C, n (%) 


























Patch, n (%) 37 (71.2) 3 (37.5) 21 (75.0) 5 (100.0) 7 (70.0) 
Recurrence,  
n (%) 
7 (13.4) 0 (0.0) 4 (14.3) 0 (0) 3 (33.3) 
Death, n (%) 7 (13.5) 1 (12.5) 1 (3.6) 1 (20.0) 4 (40.0) 
 
Table 4: Prenatal findings and outcomes 
1 patient with unknown stomach position (B defect repaired with a patch) 
 
 
